Sunitinib AqVida 12,5 mg Hartkapseln, QINLOCK 50 mg tablets
DCC-2618-03-002
Phase 3 small_molecule active
Quick answer
Sunitinib AqVida 12,5 mg Hartkapseln, QINLOCK 50 mg tablets for Patients with Advanced Gastrointestinal Stromal Tumors is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Patients with Advanced Gastrointestinal Stromal Tumors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active